Analysts Point To Dynavax Technologies Corp. (NASDAQ: DVAX) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that Dynavax to Present at TD Cowen’s 44th Annual Health Care Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NASDAQ listed company, DVAX falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $12.01 and fluctuated between $12.11 as its day high and $11.88 as its day low. The current market capitalization of Dynavax Technologies Corp. is $1.57B. A total of 1.21 million shares were traded on the day, compared to an average of 1.91M shares.

In the most recent transaction, Burgess Justin sold 20,526 shares of DVAX for 12.78 per share on Mar 01 ’24. After the transaction, the Chief Accounting Officer now owns 0 company shares. In a previous transaction on Jan 04 ’24, Janssen Robert sold 1,500 shares at 15.00 per share. DVAX shares that SVP and CMO owns now total 49,925.

Among the insiders who sold shares, Novack David F disposed of 9,000 shares on Jan 02 ’24 at a per-share price of $14.45. This resulted in the President & COO holding 3,187 shares of DVAX after the transaction. In another insider transaction, Novack David F sold 20,000 shares at $13.56 per share on Dec 01 ’23. Company shares held by the President & COO now total 3,187.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DVAX has a high of $15.15 and a low of $10.06.

As of this writing, DVAX has an earnings estimate of -$0.02 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.03 per share and a lower estimate of -$0.06. The company reported an EPS of $0.1 in the last quarter, which was 1,100.00% higher than expectations of -$0.01.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DVAX’s latest balance sheet shows that the firm has $545.95M in Cash & Short Term Investments as of fiscal 2021. There were $257.38M in debt and $556.40M in liabilities at the time. Its Book Value Per Share was $4.80, while its Total Shareholder’s Equity was $222.37M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Buy with a score of 4.60.

Most Popular

Related Posts